Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers
Clinical trial NCT07438886 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07438886
- Sponsor
- Advenchen Laboratories Nanjing Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-03-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.